LABORATORY DIAGNOSTICS FOR SYSTEMIC AUTOIMMUNE DISEASES WITH PULMONARY INVOLVEMENT
Journal Title: Pulmonologija ir alergologija - Year 2017, Vol 1, Issue 2
Abstract
Most of the systemic autoimmune diseases are related to multiorgan involvement. As expected in such a disease, the entire pulmonary system is vulnerable to injury. In this article, we present systemic autoimmune diseases which can cause lung damage. In such disease as systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis (scleroderma), polymyositis, dermatomyositis, vasculitis, Sjögren, Goodpasture and antiphospholipid syndrome, early laboratory diagnostics of autoantibodies is very important. We also review the possibilities of implementation of indirect immunofluorescence method in laboratory testing for autoantibodies.
Authors and Affiliations
Viltė Marija Gintauskienė, Margarita Paulauskienė, Brigita Šitkauskienė
Keywords
Related Articles
- EP ID EP266209
- DOI -
- Views 154
- Downloads 0
HYPERSENSITIVITY REACTIONS FROM ANTICOAGULIANTS
Anticoagulants, including heparins, coumarins, direct thrombin inhibitors (hirudins) are the most widely used drugs. Based on various mechanisms all of them can provoke immediate or delayed hypersensitivity reactions...
LUNG CANCER IMMUNOTHERAPY
The immune system plays a crucial role in protecting the body against cancer by recognizing and destroying cells it perceives as foreign. Cancer immunity strategies aim to restore immunity sy...
EOSINOPHILS VIABILITY INCREASES AFTER THEIR INTERACTION WITH AIRWAY SMOOTH MUSCLE CELLS IN ASTHMA
Background. Viability of peripheral blood eosinophils are significantly lower than airway eosinophils. It may be assumed that direct contact between eosinophils and pulmonary structural cells increase eosinophils surviva...
LABORATORY DIAGNOSTICS FOR SYSTEMIC AUTOIMMUNE DISEASES WITH PULMONARY INVOLVEMENT
Most of the systemic autoimmune diseases are related to multiorgan involvement. As expected in such a disease, the entire pulmonary system is vulnerable to injury. In this article, we present systemic autoimmune diseases...
OMALIZUMAB: SEVERE ALLERGIC ASTHMA TREATMENT OPTION
Omalizumab is a monoclonal antibody against immunoglobulin E (IgE) which prevents free IgE from interacting with the high and low affinity IgE receptors on effector cells. Results of various studies prove...